share_log

信達生物：董事名單及其角色與職能

INNOVENT BIO: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

香港交易所 ·  Feb 9 06:08
Summary by Moomoo AI
信達生物製藥INNOVENT BIOLOGICS, INC.於2024年2月9日公布了董事會成員名單及其在各董事會委員會中的角色與職能。董事會由執行董事俞德超博士擔任主席兼首席執行官，奚浩先生等人組成。獨立非執行董事包括Charles Leland Cooney博士、許懿尹女士、陳凱先博士、Gary Zieziula先生和陸舜博士。公司設有四個董事會委員會，分別為審核委員會、薪酬委員會、提名委員會和戰略委員會，各委員會成員及主席由不同董事擔任。
信達生物製藥INNOVENT BIOLOGICS, INC.於2024年2月9日公布了董事會成員名單及其在各董事會委員會中的角色與職能。董事會由執行董事俞德超博士擔任主席兼首席執行官，奚浩先生等人組成。獨立非執行董事包括Charles Leland Cooney博士、許懿尹女士、陳凱先博士、Gary Zieziula先生和陸舜博士。公司設有四個董事會委員會，分別為審核委員會、薪酬委員會、提名委員會和戰略委員會，各委員會成員及主席由不同董事擔任。
SINDA BIOPHARMACEUTICAL INNOVENT BIOLOGICS, INC. ANNOUNCED ON FEBRUARY 9, 2024 THE LIST OF BOARD MEMBERS AND THEIR ROLES AND FUNCTIONS ON EACH BOARD COMMITTEE. The Board of Directors is composed of Executive Director Dr. Yu Te-chao as Chairman and Chief Executive Officer, Mr. Chi-Hao, and others. The Independent Non-Executive Directors include Dr. Charles Leland Cooney, Ms. Xu Yi-yin, Dr. Chan Kai-sin, Mr. Gary Zieziula and Dr. Lu Shun. THE COMPANY HAS FOUR BOARD COMMITTEES, NAMELY THE AUDIT COMMITTEE, THE REMUNERATION COMMITTEE, THE NOMINATING COMMITTEE AND THE STRATEGY COMMITTEE. THE MEMBERS OF EACH COMMITTEE AND THE CHAIRMAN ARE REPRESENTED BY DIFFERENT DIRECTORS.
SINDA BIOPHARMACEUTICAL INNOVENT BIOLOGICS, INC. ANNOUNCED ON FEBRUARY 9, 2024 THE LIST OF BOARD MEMBERS AND THEIR ROLES AND FUNCTIONS ON EACH BOARD COMMITTEE. The Board of Directors is composed of Executive Director Dr. Yu Te-chao as Chairman and Chief Executive Officer, Mr. Chi-Hao, and others. The Independent Non-Executive Directors include Dr. Charles Leland Cooney, Ms. Xu Yi-yin, Dr. Chan Kai-sin, Mr. Gary Zieziula and Dr. Lu Shun. THE COMPANY HAS FOUR BOARD COMMITTEES, NAMELY THE AUDIT COMMITTEE, THE REMUNERATION COMMITTEE, THE NOMINATING COMMITTEE AND THE STRATEGY COMMITTEE. THE MEMBERS OF EACH COMMITTEE AND THE CHAIRMAN ARE REPRESENTED BY DIFFERENT DIRECTORS.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more